How to Buy Champions Oncology Stock
Champions Oncology Inc
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States.
Champions Oncology stock last closed at $6.60, down 1.93% from the previous day, and has increased 39.24% in one year. It has overperformed other stocks in the Biotechnology industry by 0.96 percentage points. Champions Oncology stock is currently +83.33% from its 52-week low of $3.60, and -44.95% from its 52-week high of $11.99.
As of Aug 27, 2025, there are 13.78M shares of CSBR outstanding. The market cap of CSBR is $90.93M. In the last 24 hours, 20,700 CSBR shares were traded.
How to Buy Champions Oncology Stock
Wondering how to invest in Champions Oncology stock? Here's how.
- Choose where to buy Champions Oncology stock: You need to choose a stock brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you determine where to buy Champions Oncology stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit funds into your brokerage account: Choose your payment method and add your information.
- Research Champions Oncology stock: The Champions Oncology ticker symbol is CSBR. Is Champions Oncology stock a good investment? Should you buy shares of CSBR? How do CSBR's underlying business fundamentals look? Do top analysts think Champions Oncology is a good buy? Why has CSBR's stock price moved recently? (Hint: Our stock research website can help you understand if CSBR is a good stock to buy).
- Execute your CSBR trade: Decide if you will purchase CSBR shares at the current market price or use a limit order to purchase CSBR shares at a specific price.
- Get updates on your investment in CSBR: Create a watchlist to monitor your new investment in Champions Oncology shares.
Step 1: Choose where to buy Champions Oncology stock
You will need a brokerage account in order to access the NASDAQ market and buy CSBR shares.
Our preferred brokerage: eToro
We believe that eToro is the best brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global financial markets: From Technology to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal information so you are able to invest in CSBR today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to create your new trading account.
- Send your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have filled out your info on the best stock market app for beginners, you can securely and quickly fund your account:
Watch the walkthrough below if you need help transferring money into your new brokerage account.
Step 4: Research Champions Oncology stock
Once you have figured out the best place to buy Champions Oncology stock, it's important to evaluate their stock before you buy, so you can comprehend the risk and upside.
Champions Oncology shares data
Champions Oncology Due Diligence Checks
WallStreetZen was designed to help average investors do more accurate fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on CSBR's stock page.
Is CSBR stock overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge CSBR's true value.
Using relative valuations metrics:
- CSBR could be undervalued based on its P/E ratio of 19.41x, relative to Biotechnology industry P/E ratio of -102.48x
- CSBR could be overvalued based on its P/B ratio of 24.11x, relative to Biotechnology industry P/B ratio of 4.58x
- CSBR may be undervalued based on its PEG ratio of 0.32x
You can do more valuation analysis on CSBR's stock here.
CSBR Financials at a glance
Signs that CSBR is financially healthy:
- CSBR profit margin has gone up from -14.5% to 8.3% in the past year.
- There are more short-term assets than long-term liabilities on the CSBR balance sheet.
- CSBR's operating cash flow of $7.39M allows it to safely service it's debt of $6.11M.
- CSBR earnings of $4.63M is not sufficient to cover its interest payments.
Signs that CSBR is not financially healthy:
- CSBR has a relatively high debt to equity ratio of 7.58.
- Total CSBR debt is higher than 5 years ago, relative to shareholder equity.
- There are more short-term liabilities than short-term assets on the CSBR balance sheet.
Do Wall Street analysts think it's a good time to buy CSBR stock
Out of 1 sell side analysts who monitor CSBR, the consensus analyst rating on Champions Oncology is a Buy
Please note that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Champions Oncology stock forecast page.
Metrics for Advanced CSBR Traders
Is CSBR Growing Revenue?
Last year, CSBR earnings were $4.70M. During the last 4 year, CSBR's earnings have gone up by 83.48% per year. This was faster than the Biotechnology industry average of 9.02%.
Last year, CSBR revenue was $56.94M. Over the past five year, CSBR's revenue has grown by 12.13% per year. This was slower than the Biotechnology industry average of 65.81%.
Dive into CSBR's earnings and revenue performance here.
Latest Insiders Trades at CSBR
Over the past year, executives and large shareholders at CSBR have bought more shares than they have sold.
Joel Ackerman, Director of CSBR, was the latest CSBR insider to buy. They bought $90,501.81 worth of CSBR stock on Oct 31, 2024.
Research more about who owns CSBR stock here.
Does CSBR stock generate passive income?
No, Champions Oncology doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your CSBR trade
There are two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are usually the easiest way to buy. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at an exact price limit, use a limit order.
Hit the Open Trade button and eToro will place the order.
If you want additional assistance buying stocks on eToro, click the how to video below:
Step 6: Get updates on your investment in CSBR
Now that you own some shares in CSBR, you'll want to keep up with your new investment.
Add CSBR to a watchlist to track the latest developments regarding your CSBR stock.
CSBR Feed
How to Buy Stock in Champions Oncology
To summarize, here are the 6 steps for buying Champions Oncology stock:
- Choose where to buy Champions Oncology stock
- Open a brokerage account
- Deposit funds into your brokerage account
- Research Champions Oncology stock
- Execute your CSBR trade
- Get updates on your investment in CSBR
If you are looking for a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to get notifications regarding your new investment in Champions Oncology, get started below.
More "How To" Guides You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.